Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.65 USD
0.00 (-0.28%)
Updated Oct 2, 2024 03:59 PM ET
After-Market: $0.66 +0.01 (2.14%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Bolt Biotherapeutics (BOLT) reported earnings of -$0.56 per share, missing the Zacks Consensus Estimate of -$0.54 per share. This reflects a negative earnings surprise of 3.70%. Look out for BOLT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 16.28%.
Earnings History
Price & Consensus
Zacks News for BOLT
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Tops Revenue Estimates
BOLT: What are Zacks experts saying now?
Zacks Private Portfolio Services